While many of these studies reported functional recovery, applying more specific drugs may provide a deeper understanding of the individual implications of EPAC2/PKA in driving regeneration in the context of SCI and NPC transplantation. This evidence concerns the gene RAPGEF4 and nasopharyngeal carcinoma.